Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial
<p>Abstract</p> <p>Purpose</p> <p>To evaluate efficacy and toxicity clinical in the intensified treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN) with the combination of chemotherapy, the EGFR antibody cetuximab, and intensity-modulated...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-04-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://www.ro-journal.com/content/7/1/57 |